|Clinical Study ID||
|Study Title||Study to assess immunogenicity, reactogenicity and safety of primary vaccination with GSK Biologicals' MenACWY vaccine (GSK134612) given as 1 or 2 doses to healthy toddlers 9-12 months of age|
|Patient Level Data||Study Listed on ClinicalStudyDataRequest.com|
|Study Recruitment Status||Completed clinical study under GSK sponsorship. The product that is studied in this clinical study, together with the rights to the data and results generated, has been transferred by GSK to Pfizer. GSK’s Clinical Study Register is no longer maintained for this study. To request access to clinical study data from Pfizer, go here: http://www.pfizer.com/research/clinical_trials/trial_data_and_results|
|Generic Name||Meningococcal Serogroups A, C, W-135 and Y-Tetanus Toxoid Conjugate Vaccine|
|Trade Name||BIO MENACWY-TT; Nimenrix|
|Study Indication||Infections, Meningococcal|
For more information on this register please email GSKClinicalSupportHD@gsk.com
GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.
IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).
This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.
EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.